12/04/2021 | BlogPost
Following the USA, Germany and France as pioneers in digital therapeutics adoption, Italy is taking action to reinforce the implementation of digital therapeutics nationwide. In January 2021, Tendenze Nuove, the official Smith Kline Foundation journal, announced the publication of ‘Digital Therapeutics, an Opportunity for Italy’, a white paper whose recommendations lay the foundational knowledge for Italian digital therapeutics ecosystem advancement and demonstrate Italy’s commitment to introducing the new class of digital therapeutics into medical practice.
Previously depicted as the distant future, the era of digital therapeutics is already here. 2020 was a game changer for digital therapeutics and digital health in general, as the emergence of COVID-19 caused a qualitative shift in the scale of new technology adoption that resulted in the ongoing evolution of healthcare towards digital, personalised and accessible treatment.
Concurrently, the pandemic sparked the willingness and readiness of all stakeholders – healthcare professionals, patients and regulators – to reinforce the implementation of digital tools. On a global scale, examples of this occurring include the video game Endeavor in the USA, which in June 2020 became the first app to receive FDA approval for the treatment of ADHD in children. 2020 was also the year digital health apps first became officially available for statutory reimbursement under the Digital Healthcare Act (DVG) in Germany.
Roberto Ascione , CEO of Healthware Group, said:
|Read the full interview on the April issue of PME|